IRADIMED CORP - Common Stock (IRMD)

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
5,523,842
Share change
+186,606
Total reported value
$187,480,258
Price per share
$33.94
Number of holders
89
Value change
+$1,615,681
Number of buys
47
Number of sells
51

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2022

As of 30 Jun 2022, IRADIMED CORP - Common Stock (IRMD) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,523,842 shares. The largest 10 holders included Nine Ten Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, Soleus Capital Management, L.P., BlackRock Inc., VANGUARD GROUP INC, RK Capital Management, LLC, Russell Investments Group, Ltd., Ranger Investment Management, L.P., ACADIAN ASSET MANAGEMENT LLC, and DIMENSIONAL FUND ADVISORS LP. This page lists 89 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.